Our findings provide a possible therapeutic strategy whereby inactivation of Id1 may lead to sensitisation of LMP1-positive NPC cells to chemotherapeutic drug induced apoptosis. This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.